This drug is a life saver Credit: pharm.com.ng
RhoGAM; What You Should Know
Generic Name: RHo (D) immune globulin
RHo (D) immune globulin (RhoGAM) is a sterilized solution containing IgG anti-D (anti-Rh)
obtained from human blood. It is a medication used to prevent Rh isoimmunization in mothers who are Rh negative. Rh is a substance that occurs naturally in the blood of most people. Such group are said to be Rh positive. But in some people, Rh is absent (Rh negative). Rh is the abbreviation for rhesus, which
is the name of one of many different blood group systems in the body. Rh-positive people have
the Rh antigen (also called rhesus factor or D antigen) on the surface of their red blood cells Rh-negative people do not have the Rh antigen on the surface of their red blood cells.
When a Rh negative mother is pregnant with a Rhesus positive child, the mother’s Rh negative blood sees the Rh positive child blood as a foreign body, thereby producing antibodies against it.
Rhesus incompatibility can be a cause of recurrent miscarriages and intrauterine fetal death in some women.
RhoGAM is an immune globulin used to prevent an immune response by the Rh negative mother
to the Rh positive child. It helps prevent the production of antibodies (Rh-sensitization). Rh-sensitization of the mother during pregnancy can lead to hemolytic disease of the fetus and newborn (HDFN) in future pregnancies. When administered, it prevents the Rh-negative expectant mother from making antibodies during pregnancy that could cause HDFN in future pregnancies.
RhoGAM is indicated for the prevention of Rh-sensitization in the following situations:
Other indications include:
o Immune thrombocytopenia purpurea (Nonsplenectomized Rh0(D)-Positive patients)
o Incompatible transfusion
How is it given?
It is administered as intravenous (I.V) or intramuscular (I.M) injection.
To prevent immune response leading to hemolytic disease in fetus and newborn, RhoGAM is
administered;
Antepartum(during pregnancy): 1500 IU at 28 – 30 weeks of gestation.
Postpartum(after delivery): 1500 IU within 72 hours of delivery. If unable to administer within 72 hours, givewithin 28 days.
Administering both antepartum and postpartum doses reduces the risk of immune responses
by over 97 percent.
In obstetric conditions such as miscarriage or abortion involving a Rh negative woman and
Rhesus positive fetus, RhoGAM should be administered at a dose of 1500 IU within 72 hours.
Side effects of RhoGAM
Most common are:
o Injection site reactions that include swelling, induration, redness and mild pain or warmth.
o Systemic reactions that include nausea, diarrhea, vomiting, stomach pain, skin rash, body
aches or a slight elevation in temperature, flushing (warmth, redness, or tingly feeling).
Patients should be observed for at least 20 minutes after administration. Severe systemic allergic
reactions are extremely rare.
Who should not use RhoGAM
RhoGAM should be administered only in a healthcare facility under the supervision of medical
expert where laboratory and other monitoring can be done.
Availability, accessibility and affordability are crucial aspects of pharmacotherapy.
RhoGAM is available in every state in Nigeria in health facilities including Government tertiary
hospitals, some private specialist hospitals and some community pharmacies.
The cost of RhoGAM vary slightly from one facility to the other. Drug revolving fund, national
health insurance scheme, brand of the drug, are some of the factors that affect the cost of the
drug.
Some facilities you are sure to get RhoGAM and price include;
Written by AIGBAGENODE Aiyebor Augustine (B.Pharm, Pharm.D)
Public Health Pharmacist
This post was last modified on September 27, 2019 6:35 pm
Leave a Comment